{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:41:17Z","timestamp":1789400477767,"version":"build-2803163510"},"reference-count":43,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2015,6,10]],"date-time":"2015-06-10T00:00:00Z","timestamp":1433894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Breast cancer has a high incidence and mortality rate worldwide. Several viral vectors including lentiviral, adenoviral and adeno-associated viral vectors have been used in gene therapy for various forms of human cancer, and have shown promising effects in controlling tumor development. Claudin1 (CLDN1) is a member of the tetraspan transmembrane protein family that plays a major role in tight junctions and is associated with tumor metastasis. However, the role of CLDN1 in breast cancer is largely unexplored. In this study, we tested the therapeutic potential of silencing CLDN1 expression in two breast cancer (MDA-MB-231 and MCF7) cell lines using lentiviral vector mediated RNA interference. We found that a CLDN1 short hairpin (shRNA) construct efficiently silenced CLDN1 expression in both breast cancer cell lines, and CLDN1 knockdown resulted in reduced cell proliferation, survival, migration and invasion. Furthermore, silencing CLDN1 inhibited epithelial to mesenchymal transition (EMT) by upregulating the epithelial cell marker, E-cadherin, and downregulating mesenchymal markers, smooth muscle cell alpha-actin (SMA) and Snai2. Our data demonstrated that lentiviral vector mediated CLDN1 RNA interference has great potential in breast cancer gene therapy by inhibiting EMT and controlling tumor cell growth.<\/jats:p>","DOI":"10.3390\/v7062755","type":"journal-article","created":{"date-parts":[[2015,6,10]],"date-time":"2015-06-10T14:05:21Z","timestamp":1433945121000},"page":"2965-2979","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Lentiviral Vector Mediated Claudin1 Silencing Inhibits Epithelial to Mesenchymal Transition in Breast Cancer Cells"],"prefix":"10.3390","volume":"7","author":[{"given":"Xianqi","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Medicine, Harbin Medical University, Harbin 150086, China"},{"name":"Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA"},{"name":"Center for Cancer Research, University of Tennessee Health Science Center, 19 S. Manassas St., Rm. 266, Memphis, TN 38163, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Medicine, Harbin Medical University, Harbin 150086, China"},{"name":"Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA"},{"name":"Center for Cancer Research, University of Tennessee Health Science Center, 19 S. Manassas St., Rm. 266, Memphis, TN 38163, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA"},{"name":"Center for Cancer Research, University of Tennessee Health Science Center, 19 S. Manassas St., Rm. 266, Memphis, TN 38163, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guannan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA"},{"name":"Center for Cancer Research, University of Tennessee Health Science Center, 19 S. Manassas St., Rm. 266, Memphis, TN 38163, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horace","family":"Gray","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA"},{"name":"Center for Cancer Research, University of Tennessee Health Science Center, 19 S. Manassas St., Rm. 266, Memphis, TN 38163, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2809-1234","authenticated-orcid":false,"given":"Lawrence","family":"Pfeffer","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA"},{"name":"Center for Cancer Research, University of Tennessee Health Science Center, 19 S. Manassas St., Rm. 266, Memphis, TN 38163, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junming","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA"},{"name":"Center for Cancer Research, University of Tennessee Health Science Center, 19 S. Manassas St., Rm. 266, Memphis, TN 38163, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,6,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1093\/annonc\/mdu206","article-title":"Trends in mortality from major cancers in the Americas: 1980\u20132010","volume":"25","author":"Chatenoud","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tibtech.2010.07.009","article-title":"RNAi and small interfering RNAs in human disease therapeutic applications","volume":"28","author":"Lares","year":"2010","journal-title":"Trends Biotechnol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ygyno.2014.07.105","article-title":"AAV-mediated persistent bevacizumab therapy suppresses tumor growth of ovarian cancer","volume":"135","author":"Xie","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1089\/hum.2013.235","article-title":"Adenovirus-based vaccines for fighting infectious diseases and cancer: Progress in the field","volume":"25","author":"Majhen","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/neuonc\/not310","article-title":"Glioma virus therapies between bench and bedside","volume":"16","author":"Kaufmann","year":"2014","journal-title":"Neuro Oncol."},{"key":"ref_6","first-page":"e12815","article-title":"Improved Adeno-associated Viral Gene Transfer to Murine Glioma","volume":"4","author":"Zolotukhin","year":"2013","journal-title":"J. Genet. Syndr. Gene Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1586\/14737140.2013.851160","article-title":"Clinical trials of viral therapy for malignant gliomas","volume":"13","author":"Piccioni","year":"2013","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.imlet.2010.03.001","article-title":"Efficient co-transduction of adenoviral vectors encoding carcinoembryonic antigen and survivin into dendritic cells by the CAR-TAT adaptor molecule enhance anti-tumor immunity in a murine colorectal cancer model","volume":"131","author":"Kim","year":"2010","journal-title":"Immunol. Lett."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.bbrc.2010.03.047","article-title":"A miR-21 hairpin structure-based gene knockdown vector","volume":"394","author":"Yue","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"13212","DOI":"10.1073\/pnas.0506306102","article-title":"A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells","volume":"102","author":"Stegmeier","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3390\/cancers5030815","article-title":"Lentiviral vectors for cancer immunotherapy and clinical applications","volume":"5","author":"Liechtenstein","year":"2013","journal-title":"Cancers"},{"key":"ref_12","first-page":"1607","article-title":"Claudins as diagnostic and prognostic markers in gynecological cancer","volume":"24","author":"Szabo","year":"2009","journal-title":"Histol. Histopathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1186\/1476-4598-13-167","article-title":"Claudin-1 overexpression in intestinal epithelial cells enhances susceptibility to adenamatous polyposis coli-mediated colon tumorigenesis","volume":"13","author":"Pope","year":"2014","journal-title":"Mol. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3892\/mmr.2013.1271","article-title":"DeltaNp63 promotes UMUC3 cell invasiveness and migration through claudin1 in vitro","volume":"7","author":"Jing","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.cellsig.2014.12.015","article-title":"PKCdelta-iPLA2-PGE2-PPARgamma signaling cascade mediates TNF-alpha induced Claudin 1 expression in human lung carcinoma cells","volume":"27","author":"Iitaka","year":"2015","journal-title":"Cell Signal."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.18632\/oncotarget.2936","article-title":"Claudin-1 enhances tumor proliferation and metastasis by regulating cell anoikis in gastric cancer","volume":"6","author":"Huang","year":"2014","journal-title":"Oncotarget"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.febslet.2013.03.023","article-title":"MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1","volume":"587","author":"Qin","year":"2013","journal-title":"FEBS Lett."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1038\/sj.onc.1210155","article-title":"Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility","volume":"26","author":"Leotlela","year":"2007","journal-title":"Oncogene"},{"key":"ref_19","first-page":"791","article-title":"Expression of CLDN1 in colorectal cancer: A novel marker for prognosis","volume":"39","author":"Nakagawa","year":"2011","journal-title":"Int. J. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/dna.2006.25.79","article-title":"Differential expression of claudin 1, 3, and 4 during normal mammary gland development in the mouse","volume":"25","author":"Blanchard","year":"2006","journal-title":"DNA Cell Biol."},{"key":"ref_21","first-page":"139","article-title":"Decreased expression of claudin-1 correlates with recurrence status in breast cancer","volume":"20","author":"Morohashi","year":"2007","journal-title":"Int. J. Mol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e112765","DOI":"10.1371\/journal.pone.0112765","article-title":"A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer","volume":"9","author":"Ma","year":"2014","journal-title":"PLoS ONE"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1186\/1471-2407-13-268","article-title":"Claudin 1 expression in basal-like breast cancer is related to patient age","volume":"13","author":"Blanchard","year":"2013","journal-title":"BMC Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e548","DOI":"10.1186\/1471-2407-10-548","article-title":"Anti-apoptotic effect of claudin-1 in tamoxifen-treated human breast cancer MCF-7 cells","volume":"10","author":"Akasaka","year":"2010","journal-title":"BMC Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1158\/1078-0432.CCR-13-1330","article-title":"Targeting epithelial-to-mesenchymal transition with Met inhibitors reverts chemoresistance in small cell lung cancer","volume":"20","author":"Canadas","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_26","first-page":"277","article-title":"Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells","volume":"31","author":"Kajiyama","year":"2007","journal-title":"Int. J. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1158\/0008-5472.CAN-11-0036","article-title":"Notch signaling activated by replication stress-induced expression of midkine drives epithelial-mesenchymal transition and chemoresistance in pancreatic cancer","volume":"71","author":"Gungor","year":"2011","journal-title":"Cancer Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.maturitas.2014.06.015","article-title":"Targeting the Twist and Wnt signaling pathways in metastatic breast cancer","volume":"79","author":"Glackin","year":"2014","journal-title":"Maturitas"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1797","article-title":"The origin of vimentin expression in invasive breast cancer: Epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential?","volume":"206","author":"Korsching","year":"2005","journal-title":"J. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e57329","DOI":"10.1371\/journal.pone.0057329","article-title":"Klf4 is a transcriptional regulator of genes critical for EMT, including Jnk1 (Mapk8)","volume":"8","author":"Tiwari","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.4161\/cc.10.8.15363","article-title":"p53-dependent regulation of growth, epithelial-mesenchymal transition and stemness in normal pancreatic epithelial cells","volume":"10","author":"Pinho","year":"2011","journal-title":"Cell Cycle"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/ncb1998","article-title":"The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs","volume":"11","author":"Wellner","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s11095-013-1219-9","article-title":"Silencing the Double-Stranded RNA Binding Protein DGCR8 Inhibits Ovarian Cancer Cell Proliferation, Migration, and Invasion","volume":"32","author":"Guo","year":"2015","journal-title":"Pharm. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e105331","DOI":"10.1371\/journal.pone.0105331","article-title":"Doxycycline inducible Kruppel-like factor 4 lentiviral vector mediates mesenchymal to epithelial transition in ovarian cancer cells","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS ONE"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e956897","DOI":"10.1155\/2010\/956897","article-title":"Claudin 1 in breast tumorigenesis: Revelation of a possible novel \u201cclaudin high\u201d subset of breast cancers","volume":"2010","author":"Myal","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/his.12490","article-title":"Distinct claudin expression characterizes BRCA1-related breast cancer","volume":"65","author":"Smolders","year":"2014","journal-title":"Histopathology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/modpathol.2012.187","article-title":"Claudin expression in high-grade invasive ductal carcinoma of the breast: Correlation with the molecular subtype","volume":"26","author":"Lu","year":"2013","journal-title":"Mod. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00428-009-0770-6","article-title":"Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype","volume":"454","author":"Blanchard","year":"2009","journal-title":"Virchows Arch."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e68630","DOI":"10.1371\/journal.pone.0068630","article-title":"Methylation of the claudin 1 promoter is associated with loss of expression in estrogen receptor positive breast cancer","volume":"8","author":"Cope","year":"2013","journal-title":"PLoS ONE"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s13277-012-0493-1","article-title":"Anti-apoptotic effect of claudin-1 on TNF-alpha-induced apoptosis in human breast cancer MCF-7 cells","volume":"33","author":"Liu","year":"2012","journal-title":"Tumour Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/ijc.11571","article-title":"Reexpression of the TJ protein CLDN1 induces apoptosis in breast tumor spheroids","volume":"108","author":"Hoevel","year":"2004","journal-title":"Int. J. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1042\/BJ20050591","article-title":"The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells","volume":"394","author":"Culleres","year":"2006","journal-title":"Biochem. J."},{"key":"ref_43","first-page":"77","article-title":"Suppression of human breast tumors in NOD\/SCID mice by CD44 shRNA gene therapy combined with doxorubicin treatment","volume":"5","author":"Vu","year":"2012","journal-title":"OncoTargets Ther."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/7\/6\/2755\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:47:42Z","timestamp":1760215662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/7\/6\/2755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,10]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6]]}},"alternative-id":["v7062755"],"URL":"https:\/\/doi.org\/10.3390\/v7062755","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,10]]}}}